Imagine you are reviewing a mid-cap textile manufacturer that has just announced a 1-for-5 rights issue at a significant discount to its current market price of ₹500. As an analyst, your task is not merely to note the...
Imagine you are reviewing a draft investment thesis for a mid-cap pharmaceutical firm that has just announced a rights issue. Your junior analyst focuses solely on the dilution effect on Earnings Per Share, but you...
Imagine you are reviewing the quarterly performance of a mid-cap pharmaceutical company. Your valuation model suggests a steady earnings growth trajectory, but suddenly, the board announces a rights issue to fund a new...